Union Health Minister Ghulam Nabi Azad on Wednesday admitted that the recent Supreme Court ruling on, and stringent regulations for, clinical trials had set drugs research back in India. But he was hopeful that the sector would gather pace again.
“We received a setback because not many pharmaceutical companies are coming forward for clinical trials now. There has been a 50 per cent drop in clinical trials after stringent regulations were put in place, but we are hopeful that they will pick up in the coming days,” he told The Hindu.
Source: The Hindu
News on Other Repro Health
This is a collection of news clippings from differnt newspapers on other reproductive health issues